Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

NJ Economic Development Authority (EDA)

NJEDA: Ideal Location, Unique State Resources Give Enteris BioPharma Advantage in Global Marketplace

Trenton, NJ, June 25, 2017 — This week’s BIO International Convention gave leaders from New Jersey’s vast life sciences ecosystem the chance to show emerging companies the advantages of establishing themselves within the State, such as its ideal location on the Eastern seaboard and the large number of pharmaceutical giants that currently call the State “home.”

“The Garden State is truly the best place to start a biopharmaceutical company,” New Jersey Economic Development Authority (EDA) Chief Executive Officer (CEO) Melissa Orsen said. Continue reading

Ex-Roche Campus Reinvented as ‘On3’ Science Center; Developer Seeks to Create Mini-Metropolis in the Suburbs’ for Life Sciences

Nutley, NJ, June 23, 2017 — Owen Proctor reports in The Record/NorthJersey.com that the former Hoffmann-La Roche campus that borders Clifton and Nutley has a new name.

“On3” seeks to incorporate living, working and playing in the Route 3 site, according to Prism Capital Partners’ principal Eugene Diaz. He described the redevelopment as “a mini-metropolis in the suburbs.”

The firm wants to reinvent the 116-acre campus that the pharmaceutical giant began vacating in 2012, creating a synergy among like-minded businesses geared toward life sciences. Continue reading

NJEDA Urges Emerging Tech and Life Sciences Companies to Apply for Funding

Trenton, DC, June 15, 2017 — Brandon Scalea reports in The Star-Ledger that an application administered by the New Jersey Economic Development Authority (EDA) is available for early-stage companies to gain access to capital.

The New Jersey Technology Business Tax Certificate Transfer (NOL) Program is targeted to up-and-coming technology and life science companies in the state. The online application is due June 30.

Kathleen Coviello, EDA director of technology and life sciences, said all eligible companies should take advantage of this opportunity. Continue reading

NJ EDA to Fill Market Need for Seed-Stage Capital Through NJ CoVest Fund; Aims to Help New Innovative Tech and Life Science Companies Thrive

Trenton, NJ, April 18, 2017 — The New Jersey Economic Development Authority (EDA) on April 13 announced the creation of the NJ CoVest Fund, which will provide growth capital to early-stage technology and life sciences companies, driving up to $9 million in investment.

The NJ CoVest Fund will fill a market need in New Jersey, ensuring the availability of capital at a company’s critical stage between product development and commercial operation expansion, where limited funds are currently available and a funding gap exists. Continue reading

Gov. Christie’s Chief Counsel Thomas Scrivo Stepping Down to Chair NJ Economic Development Authority and Return to Private Practice

Thomas Scrivo

Trenton, NJ, March 13, 2017 — Thomas P. Scrivo, Governor Chris Christie’s Chief Counsel, will leave the Administration following a year and a half of service, but the Governor has appointed Scrivo to serve as the new Chairman of the New Jersey Economic Development Authority (NJEDA).

In addition, Mr. Scrivo will return to private practice and form the law firm of O’Toole Scrivo with Senator Kevin O’Toole.

Succeeding Scrivo as Chief Counsel to the Governor will be Gregory Acquaviva, Vice President of State Government Affairs at UnitedHealth Group and former Chief of Staff to Lt. Governor Kim Guadagno. Continue reading

NJEDA’s Angel Investor Tax Credit Fuels Investment in NJ Biotechnology Firms

Trenton, NJ, March 1, 2017New Jersey Business reports that New Jersey’s Angel Investor Tax Credit Program boosted investment in local tech firms to a record number in 2016.

As Lilo Stainton reported in the news website NJ Spotlight, the NJ Economic Development Authority (EDA) approved 251 applications for angel investor tax credits that spurred more than $96 million in private investments, the highest annual total since the program was launched three years ago. Continue reading

Surge of NJEDA Approvals Closes Out Active 2016 for State’s Angel Investor Tax Credit Program

Trenton, NJ, February 28, 2017 — The New Jersey Economic Development Authority (EDA) recently announced the approval of a record-breaking 251 applications through the state’s Angel Investor Tax Credit Program in 2016, representing the injection of more than $96 million in private capital into technology and life sciences companies throughout the Garden State.

In the fourth quarter of 2016 alone, the EDA approved 198 applications. Continue reading

NJEDA Creates Programs to Enhance Commercial Corridors in Garden State Growth Zones Designed to Stimulate Small Business Sector

Trenton, NJ, February 19, 2017 — The Board of the New Jersey Economic Development Authority (EDA) acted on February 14 to expand support of small business growth in Garden State Growth Zones (GSGZs) through the creation of the Business Lease Incentive (BLI) and Business Improvement Incentive (BII) programs.

The BLI and BII programs are designed to support the growth of retail and services in GSGZs by providing grants to street level new and expanding businesses. Continue reading

EDA-Supported Medical Device Companies Among Those Joining Global Fight Against Heart Disease

Trenton, NJ, February 5, 2017 — In honor of American Heart Month and “National Wear Red Day®,” both of which are designed to raise awareness of cardiovascular disease, @NJEDATech highlights two New Jersey Economic Development Authority (EDA)-supported technology companies that are helping to combat the devastating effects of the disease.

The American Heart Association (AHA) notes that heart disease is the leading cause of death in the world, killing more than 370,000 Americans a year. Continue reading

Today! HINJ, BioNJ and NJ Tech Council Partner on NJEDA’s ‘Early Stage Biotech Investing in 2017’ Strategies Forum on January 17

Register Here SquareTrenton, NJ, January 17, 2017 — The HealthCare Institute of New Jersey (HINJ), BioNJ and the New Jersey Tech Council are partnering with the New Jersey Economic Development Authority (NJEDA) to present “Early Stage Biotech Investing in 2017: Strategies for a Changing Environment.”

The forum will be held on Tuesday, January 17 from 4:30 to 6:30 p.m. at the Commercialization Center for Innovative Technologies (CCIT), a life sciences incubator, at 675 US Highway One, North Brunswick, New Jersey.

The aim of the forum is to present an insightful conversation about how life sciences companies will be funded by venture capital firms in 2017.  Continue reading